BPC-157 is among the most heavily marketed research peptides and among the least tested in people. Both of those things are true at once, and the gap between them is the story.
What it is
BPC-157 is a synthetic chain of 15 amino acids based on a sequence found in a protein in gastric juice. The name stands for Body Protection Compound.
What the research actually consists of
- Rodent studies, many of them. Reported faster healing of tendon, ligament, muscle and gut injuries, and protection of the stomach lining.
- Laboratory work on blood vessel formation, nitric oxide signalling and cell migration, offering proposed mechanisms.
- Human trials: no completed, published, placebo-controlled trial demonstrating that it heals injuries in people.
That last line is the one that matters. Every claim about tendon recovery or gut healing in humans is an extrapolation across a species barrier that drug development crosses successfully only a minority of the time.
The concentration problem
A large share of the published work originates from a small number of connected research groups. Independent replication by unaffiliated laboratories is limited. This does not make the findings wrong, but it means the evidence has not been stress-tested the way a mature result has.
Safety
Unknown in humans, because the studies that would establish it have not been done. Animal studies have not reported obvious toxicity. The most commonly raised theoretical concern is that promoting blood vessel growth is also a feature of tumour growth, which is a reason for caution rather than a demonstrated harm.
The 2026 FDA advisory vote
In July 2026 an FDA advisory committee voted 8 to 6, with one abstention, to recommend BPC-157 for possible inclusion on the list of substances compounding pharmacies may use. The vote is widely misreported, so the details matter:
- The vote is advisory and non-binding. The FDA decides.
- FDA’s own scientists recommended against all seven peptides under review, finding the studies too short and too small.
- Nothing has been added to any list. That would require a proposed rule, a comment period and a final rule.
- It is not an approval.
BPC-157 is on the World Anti-Doping Agency’s prohibited list. Athletes subject to testing risk a ban.